Companies

Axiom Bio

axi.om

Axiom Bio provides AI-driven frontier intelligence for human drug toxicity to develop safer medicines.

Employees11-50
Funding$41.4M
Valuation$60-90M
7 active roles
Healthcare AIAI ApplicationB2B SaaS$10M-$50M

About

Axiom Bio is a San Francisco-based biotechnology firm operating at the intersection of machine learning, biochemistry, and life sciences. The company develops AI-driven predictive models to provide frontier intelligence for human drug toxicity, enabling scientists to reduce unexpected toxicity and develop safer medicines with less animal testing.

Active Roles

7
SF Global HQ/Other/3d ago
SF Global HQ/Engineering/9d ago
SF Global HQ/Other/9d ago
SF Global HQ/Other/10d ago
SF Global HQ/Other/11d ago

Key Investors

Crane Venture Partners